Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and α-synuclein accumulation in the colon of two Parkinson's disease mouse models
Yunfang Su, Ningning Liu, Zijuan Zhang, Zijuan Zhang, Hao Li, Jinlian Ma, Ye Yuan, Ming Shi, Jihong Liu, Zhenrong Zhao, Zhenqiang Zhang, Zhenqiang Zhang, Christian Hölscher
Topics & Concepts
CholecystokininDopaminergicMPTPEndocrinologyInternal medicineGlial cell line-derived neurotrophic factorGlucagon-like peptide-2Neurotrophic factorsTyrosine hydroxylaseInflammationParkinson's diseaseVasoactive intestinal peptideGenetically modified mouseBiologyDopamineMedicineNeuropeptideTransgeneReceptorPeptideBiochemistryDiseaseGeneRegulation of Appetite and ObesityParkinson's Disease Mechanisms and TreatmentsBiochemical effects in animals